On June 22, 2026, Aditxt, Inc. entered into an amendment to its June 3, 2026, Note Purchase Agreement with Ignite Proteomics LLC and various investors. This amendment increases the aggregate original principal amount of newly issued senior secured convertible notes to $6,254,355.17. As part of this transaction, the company and its subsidiary, Ignite, issued and sold additional notes with an original principal amount of $769,230.77 for a cash purchase price of $500,000.00. The notes are secured by substantially all assets of Ignite and the equity held by Aditxt in Ignite. Aditxt, Inc. is a healthcare technology company.
